Pharmacy Retail Market in Philippines 2013
The report is sent in 0-2 business days after order is placed.
Netscribes’ latest market research report titled Pharmacy Retail Market in Philippines 2013 identifies the healthcare scenario, more specifically, the pharmacy retail scenario in the Philippines. The sector is dotted with a wide variety of drug distributors, wholesalers, retailers and manufacturers and has also witnessed a spurt in the number of both domestic and foreign concerns in the recent past. The country has been in the wake of a revolution with regard to decentralization of the healthcare system with precise concentration on local health provision and ramified coverage. The sector can be categorized into organized and unorganized markets, with the unorganized segment accounting for the major market share.
Although a developing country, the Philippines is already being hailed as a prospective market for entry of pharmaceutical companies, which is evident in the growing number of pharmaceutical majors establishing manufacturing facilities within the nation. Moreover, this sector is termed as being profitable owing to the fact that there is marginal price elasticity associated with price increases. The market is characterized by the presence of a few large players that account for significant market share and boast of having a considerable footprint across the nation.
Netscribes’ latest market research report titled Pharmacy Retail Market in Philippines 2013 identifies the healthcare scenario, more specifically, the pharmacy retail scenario in the Philippines. The sector is dotted with a wide variety of drug distributors, wholesalers, retailers and manufacturers and has also witnessed a spurt in the number of both domestic and foreign concerns in the recent past. The country has been in the wake of a revolution with regard to decentralization of the healthcare system with precise concentration on local health provision and ramified coverage. The sector can be categorized into organized and unorganized markets, with the unorganized segment accounting for the major market share.
Although a developing country, the Philippines is already being hailed as a prospective market for entry of pharmaceutical companies, which is evident in the growing number of pharmaceutical majors establishing manufacturing facilities within the nation. Moreover, this sector is termed as being profitable owing to the fact that there is marginal price elasticity associated with price increases. The market is characterized by the presence of a few large players that account for significant market share and boast of having a considerable footprint across the nation.
INTRODUCTION
Slide 1: Philippines – Demographics (2012)
PHARMACEUTICAL MARKET OVERVIEW
Slide 2: Pharmaceutical Market in Philippines – Overview, Market Size & Growth (2008-2013e), Segmentation (2012)
REGULATIONS TO OPEN PRIVATE PHARMACIES
Slide 3-9: Regulations
Slide 10-11: FDA Regulations & Basic Checklist
Slide 12-14: Prerequisites for the Practice of Pharmacy
Slide 15-16: Foreign Investment Scenario
DISTRIBUTION OF PUBLIC V/S PRIVATE SECTOR PHARMACIES
Slide 17: Classification
Slide 18: Philippines Private Pharmacy Retail Outlets
Slide 19-20: Philippines Public-Private Partnership Pharmacy Retail Outlets
Slide 21: Philippines Public Pharmacy Retail Outlets
Slide 22: Distribution of Public vs Private Sector Pharmacies
PERFORMANCE REVIEW OF PRIVATE PHARMACIES
Slide 23: SWOT Analysis – Private Chain Pharmacy
Slide 24-44: Company Profiles
Slide 45: Chain Pharmacies – Comparative Analysis
Slide 46: Private Standalone Pharmacies in Philippines
SUPPLY CHAIN ANALYSIS
Slide 47-48: Supply Chain Analysis – Overview
Slide 49-53: Types
IMPORTATION POLICY
Slide 54-56: Parallel Drug Importation
MARK-UPS ON MEDICINE PRICE – DISTRIBUTION CHANNEL-WISE
Slide 57: Pharmaceutical Distribution Channel in Philippines
Slide 58: Analysis of Mark ups on Medicine Price (Originator Brand and Generics)
Slide 59: Manufacturer’s Selling Price (MSP)
Slide 60: Landed Cost
Slide 61-62: Wholesaler
Slide 63-64: Retailer
Slide 65: Dispensed Cost
INSURANCE PENETRATION
Slide 66: Health Insurance – Overview
Slide 67-69: Types of Health Insurance
Slide 70: Reimbursement – Discount Card in Pharmacies
Slide 71: Reimbursement – Public Private Partnership Scheme
SALARY STRUCTURE
Slide 72: Compensation
CONCLUSION
Slide 73: Conclusion – Road Ahead
APPENDIX
Slide 74: Appendix
Slide 75: Sources of Information
Slide 1: Philippines – Demographics (2012)
PHARMACEUTICAL MARKET OVERVIEW
Slide 2: Pharmaceutical Market in Philippines – Overview, Market Size & Growth (2008-2013e), Segmentation (2012)
REGULATIONS TO OPEN PRIVATE PHARMACIES
Slide 3-9: Regulations
Slide 10-11: FDA Regulations & Basic Checklist
Slide 12-14: Prerequisites for the Practice of Pharmacy
Slide 15-16: Foreign Investment Scenario
DISTRIBUTION OF PUBLIC V/S PRIVATE SECTOR PHARMACIES
Slide 17: Classification
Slide 18: Philippines Private Pharmacy Retail Outlets
Slide 19-20: Philippines Public-Private Partnership Pharmacy Retail Outlets
Slide 21: Philippines Public Pharmacy Retail Outlets
Slide 22: Distribution of Public vs Private Sector Pharmacies
PERFORMANCE REVIEW OF PRIVATE PHARMACIES
Slide 23: SWOT Analysis – Private Chain Pharmacy
Slide 24-44: Company Profiles
Slide 45: Chain Pharmacies – Comparative Analysis
Slide 46: Private Standalone Pharmacies in Philippines
SUPPLY CHAIN ANALYSIS
Slide 47-48: Supply Chain Analysis – Overview
Slide 49-53: Types
IMPORTATION POLICY
Slide 54-56: Parallel Drug Importation
MARK-UPS ON MEDICINE PRICE – DISTRIBUTION CHANNEL-WISE
Slide 57: Pharmaceutical Distribution Channel in Philippines
Slide 58: Analysis of Mark ups on Medicine Price (Originator Brand and Generics)
Slide 59: Manufacturer’s Selling Price (MSP)
Slide 60: Landed Cost
Slide 61-62: Wholesaler
Slide 63-64: Retailer
Slide 65: Dispensed Cost
INSURANCE PENETRATION
Slide 66: Health Insurance – Overview
Slide 67-69: Types of Health Insurance
Slide 70: Reimbursement – Discount Card in Pharmacies
Slide 71: Reimbursement – Public Private Partnership Scheme
SALARY STRUCTURE
Slide 72: Compensation
CONCLUSION
Slide 73: Conclusion – Road Ahead
APPENDIX
Slide 74: Appendix
Slide 75: Sources of Information
